City Therapeutics, Inc. (CTY)

City Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

City Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-87.67	-58.51	-27.84
Depreciation & Amortization	1.46	1.17	0.42
Share-Based Compensation	-	3	1.01
Other Operating Activities	8.53	12.73	6.02
Operating Cash Flow	-77.67	-41.61	-20.39
Operating Cash Flow Growth	-	-	-

Investing Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Capital Expenditures	-3.08	-2.41	-3.54
Other Investing Activities	0.03	0.03	0.16
Investing Cash Flow	-3.05	-2.38	-3.38

Financing Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Share Issuance / Repurchase	-	0.89	134.44
Debt Issued / Paid	-	29.97	15
Financing Cash Flow	101.05	30.86	149.44

Net Cash Flow

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Cash Flow	20.33	-13.13	125.67

Free Cash Flow

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-80.75	-44.02	-23.93
Free Cash Flow Growth	-	-	-
Free Cash Flow Margin	-563.00%	-324.55%	-861.34%